resveratrol has been researched along with 2019 Novel Coronavirus Disease in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 26 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deres, L; Gal, R; Habon, T; Halmosi, R; Toth, K | 1 |
| Duan, X; Xiang, T; Xiao, Z; Ye, Q | 1 |
| Chen, X; Hao, R; Huang, B; Li, J; Song, S; Su, G; Sun, M; Wang, G; Wang, N; Xiao, Z; Xu, H; Zhou, D | 1 |
| Ahmadian, R; Biganeh, H; Guest, PC; Jamialahmadi, T; Panahi, Y; Sahebkar, A | 1 |
| van Brummelen, AC; van Brummelen, R | 1 |
| Abd El-Halim, SM; Abourehab, MAS; Beshay, BY; Zakaria, MY; Zaki, I | 1 |
| Böhmdorfer, M; Gattinger, P; Gawish, R; Hardt, M; Jäger, W; Kicker, E; Knapp, S; Szekeres, T; Valenta, R; Zatloukal, K | 1 |
| Chen, H; Ding, C; Duanmu, D; Li, W; Peng, Q; Qiao, J; Sun, B; Wang, C; Wang, Y; Ye, X; You, Q; Zhou, M; Zong, S | 1 |
| Ho, CT; Koh, YC; Pan, MH | 1 |
| Jabłońska, J; Kluska, M; Prukała, W | 1 |
| Malaguarnera, L; Romano, IR; Russo, C; Valle, MS | 1 |
| Lei, S; Song, XQ; Wang, Z; Xu, W; Yang, L; Zhang, H | 1 |
| Marinella, MA | 1 |
| Di Pietro, M; Filardo, S; Mastromarino, P; Sessa, R | 1 |
| Han, YJ; Ji, XY; Li, XX; Ma, CY; Ren, ZG; Wu, DD; Yan, JL | 1 |
| Jamshidi, M; Ranjbar, A; Torabi, S | 1 |
| Bachari, K; Ramdani, LH | 1 |
| Grebenchikov, OA; Zinovkin, RA | 1 |
| Hoang, T | 1 |
| Doustimotlagh, AH; Eftekhari, M | 1 |
| Ćirković Veličković, T; Gligorijević, N; Khulal, U; Nedić, O; Radomirović, M; Stanić-Vučinić, D; Stojadinović, M | 1 |
| Augusti, PR; Bronze, MR; Conterato, GMM; Denardin, CC; Emanuelli, T; Prazeres, ID; Serra, AT | 1 |
| Coppola, F; Fuggetta, MP; Montesarchio, D; Musumeci, D; Perrella, F; Petrone, A; Platella, C; Ravagnan, G; Rega, N; Stringaro, A | 1 |
| Apperloo, L; Bouma, EM; Dinesh Kumar, N; Moser, J; Nawijn, MC; Rodenhuis-Zybert, IA; Smit, JM; Ter Ellen, BM; Troost, B; van de Pol, DPI; van den Berge, M; van der Ende-Metselaar, HH; van der Voort, PHJ; van Gosliga, D | 1 |
| Jiang, Y; Liu, C; Liu, X; Wang, T; Wu, H; Wu, P; Yan, Q; Zhan, S; Zheng, W | 1 |
| Blaak, EE; de Ligt, M; Goossens, GH; Hesselink, MKC; Hoebers, N; Jorgensen, J | 1 |
10 review(s) available for resveratrol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Diseases; Cardiovascular System; COVID-19; COVID-19 Drug Treatment; Humans; Resveratrol | 2021 |
The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator's perspective.
Topics: Antioxidants; Antiviral Agents; COVID-19; Cytokines; Down-Regulation; Drug Therapy, Combination; Humans; Oxidative Stress; Resveratrol; SARS-CoV-2 | 2022 |
The Role of Mitochondria in Phytochemically Mediated Disease Amelioration.
Topics: COVID-19; Curcumin; Humans; Mitochondria; Mitochondrial Dynamics; Post-Acute COVID-19 Syndrome; Resveratrol | 2023 |
Analytics, Properties and Applications of Biologically Active Stilbene Derivatives.
Topics: Antifungal Agents; COVID-19; Humans; Preservatives, Pharmaceutical; Resveratrol; Stilbenes | 2023 |
Comparison of Vitamin D and Resveratrol Performances in COVID-19.
Topics: COVID-19; Humans; Inflammation; Resveratrol; SARS-CoV-2; Vitamin D; Vitamins | 2023 |
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Topics: Antiviral Agents; COVID-19; Curcumin; Gossypol; Humans; Pandemics; Polyphenols; Resveratrol; SARS-CoV-2 | 2023 |
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases | 2020 |
Advances and challenges in the prevention and treatment of COVID-19.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Chloroquine; Chlorpromazine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclophilins; Drug Development; Drug Repositioning; Drugs, Chinese Herbal; Endocytosis; Humans; Immune Sera; Interferon Inducers; Nucleic Acid Synthesis Inhibitors; Pandemics; Pneumonia, Viral; Pyrazines; Resveratrol; SARS-CoV-2; Viral Vaccines | 2020 |
Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.
Topics: Biological Availability; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; Resveratrol; SARS-CoV-2 | 2021 |
Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Biological Availability; COVID-19; Curcumin; Dietary Supplements; Gastrointestinal Microbiome; Humans; Immunologic Factors; Phenols; Quercetin; Resveratrol; SARS-CoV-2 | 2021 |
1 trial(s) available for resveratrol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Resveratrol supplementation reduces ACE2 expression in human adipose tissue.
Topics: Adipose Tissue; Angiotensin-Converting Enzyme 2; COVID-19; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Down-Regulation; Humans; Leptin; Male; Middle Aged; Obesity; Placebo Effect; Receptor, Angiotensin, Type 1; Resveratrol; SARS-CoV-2 | 2021 |
15 other study(ies) available for resveratrol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related Hyperinflammation.
Topics: Anti-Inflammatory Agents; COVID-19; Gene Ontology; Genes, Viral; Humans; Inflammation; Molecular Docking Simulation; Protein Interaction Maps; Resveratrol; SARS-CoV-2 | 2021 |
Effective inhibition of coronavirus replication by
Topics: Antiviral Agents; Cell Line, Tumor; Cell Survival; COVID-19; Drugs, Chinese Herbal; Fallopia japonica; Glucosides; HEK293 Cells; Host-Pathogen Interactions; Humans; Medicine, Chinese Traditional; Pandemics; Protein Binding; Resveratrol; SARS-CoV-2; Stilbenes; Surface Plasmon Resonance; Viral Proteins; Virus Replication | 2021 |
Resveratrol as a Probable Multiheaded Treatment Approach for COVID-19.
Topics: COVID-19; Humans; Pandemics; Resveratrol; SARS-CoV-2 | 2021 |
'Poly phenolic phytoceutical loaded nano-bilosomes for enhanced caco-2 cell permeability and SARS-CoV 2 antiviral activity': in-vitro and insilico studies.
Topics: Antiviral Agents; Caco-2 Cells; COVID-19; Humans; Particle Size; Permeability; Polyethylene Glycols; Resveratrol; RNA, Viral; SARS-CoV-2 | 2023 |
Identification of a Synthetic Polyhydroxyphenolic Resveratrol Analogue, 3,3',4,4',5,5'-Hexahydroxy-
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Humans; Pandemics; Protein Binding; Resveratrol; SARS-CoV-2 | 2023 |
Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry.
Topics: Cathepsin L; COVID-19; Humans; Molecular Docking Simulation; Resveratrol; SARS-CoV-2; Virus Internalization | 2023 |
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
Topics: Animals; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclooxygenase Inhibitors; Cytokines; Dogs; Humans; Indomethacin; Pandemics; Pneumonia, Viral; Resveratrol; SARS-CoV-2; Virus Replication | 2020 |
Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; Coronavirus Infections; Coronavirus Papain-Like Proteases; COVID-19; Crystallography, X-Ray; Hydrogen Bonding; Molecular Docking Simulation; Pandemics; Papain; Pneumonia, Viral; Protein Structure, Tertiary; Resveratrol; RNA-Dependent RNA Polymerase; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Nonstructural Proteins | 2020 |
Potential therapeutic effects of Resveratrol against SARS-CoV-2.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Resveratrol; SARS-CoV-2 | 2020 |
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
Topics: Animals; Antioxidants; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Dimethyl Fumarate; Female; Humans; Immunosuppressive Agents; Inflammation; Isothiocyanates; Male; Mice; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidative Stress; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Resveratrol; SARS-CoV-2; Signal Transduction; Sulfoxides; Thiosulfates | 2020 |
An approach of fatty acids and resveratrol in the prevention of COVID-19 severity.
Topics: COVID-19; Dietary Supplements; Fatty Acids; Humans; Resveratrol; Stilbenes | 2021 |
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.
Topics: Anti-Inflammatory Agents; Antioxidants; COVID-19; COVID-19 Drug Treatment; Glucosephosphate Dehydrogenase; Glucosides; Humans; Inflammation; Lung; Magnoliopsida; Oxidative Stress; Pandemics; Phytotherapy; Plant Extracts; Resveratrol; SARS-CoV-2; Stilbenes | 2021 |
Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drugs, Chinese Herbal; Enzyme Inhibitors; Glucosides; Host-Pathogen Interactions; Humans; Molecular Docking Simulation; Protein Binding; Resveratrol; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stilbenes | 2021 |
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
Topics: Animals; Antiviral Agents; Bronchi; Cell Line; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Epithelial Cells; Female; Humans; Male; Middle Aged; Resveratrol; SARS-CoV-2; Stilbenes; Vero Cells; Virus Replication | 2021 |
Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
Topics: Antiviral Agents; Chemokine CCL2; Coinfection; Computational Biology; COVID-19; COVID-19 Drug Treatment; Dengue; Dengue Virus; Dexamethasone; Gene Expression Regulation; Genistein; Humans; Intercellular Adhesion Molecule-1; Lung; Protein Interaction Maps; Resveratrol; SARS-CoV-2; Signal Transduction | 2021 |